Singapore markets close in 3 hours 51 minutes

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.25+0.07 (+0.49%)
At close: 04:00PM EST
14.31 +0.06 (+0.42%)
After hours: 07:53PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
4,406
152
152
152
Operating expenses
Research development
202,894
165,896
154,180
159,391
Selling general and administrative
139,537
107,850
15,027
15,161
Total operating expenses
342,431
273,746
169,207
174,552
Operating income or loss
-338,605
-273,594
-169,055
-174,400
Interest expense
5,850
6,329
5,287
-
Total other income/expenses net
1,474
542
1,471
61
Income before tax
-342,981
-279,381
-172,871
-173,482
Income from continuing operations
-342,981
-279,381
-172,871
-173,482
Net income
-342,981
-279,381
-172,871
-173,482
Net income available to common shareholders
-342,981
-279,381
-172,871
-173,482
Basic EPS
-
-2.42
-1.96
-2.30
Diluted EPS
-
-2.42
-1.96
-2.30
Basic average shares
-
115,334
88,369
75,467
Diluted average shares
-
115,334
88,369
75,467
EBITDA
-
-272,894
-167,484
-174,312